Expert Analysis

Detection, Diagnosis, Screening, and Prevention

Source: CCO Independent Conference Coverage of the 2006 Annual San Antonio Breast Cancer Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Detection, Diagnosis, Screening, and Prevention


Faculty:

  • William J. Gradishar, MD, FACP
  • Daniel F. Hayes, MD
  • Hope S. Rugo, MD

CME CREDIT INFORMATION

Release Date: 02/08/07

Expiration Date: 02/07/08


Physicians: maximum of 1.75 AMA PRA Category 1 Credit(s)

Pharmacists: 1.8 contact hours (0.18 CEUs)

Registered Nurses: 1.8 Nursing CE credits

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the results of recent clinical trials for the treatment of breast cancer
  • Describe new techniques for the detection, screening, and prevention of breast cancer
  • Recall prognostic developments in the management of breast cancer treatment

Topics covered include:

  • The Human Mammary Tumor Virus as a Contributing Cause of Breast Cancer
  • Assessment of Tamoxifen and Raloxifene for Breast Cancer Prevention
  • Breast Cancer Risk Assessment Based on Breast Density
  • Detection of Breast Cancers by Ultrasound
  • Prognostic Significance of Nuclear ERβ2 Expression
  • Predictive Value of Lymphovascular Invasion for Positive Sentinel Node Biopsy
  • Significance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow
  • Predictive Value of β-Tubulin Isoform Expression and the Response to Paclitaxel
  • WINS: Association Between a Low-Fat Diet and Breast Cancer Outcomes


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.